haloperidol has been researched along with benzoxazoles in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boissier, JR; Simon, P; Soubrié, P; Thiébot, MH | 1 |
| Kleinrok, Z; Kolasa, K; Rajtar, G | 1 |
| Hashimoto, S; Khotib, J; Miyatake, M; Nagumo, Y; Nakamachi, T; Narita, M; Sakurai, T; Shioda, S; Suzuki, T; Yanagisawa, M | 1 |
| Assié, MB; Carilla-Durand, E; Cosi, C; Leduc, N; Maraval, M; Newman-Tancredi, A; Ormiere, AM | 1 |
| Hsu, MA; Rasmussen, K; Yang, Y | 1 |
| Hemrick-Luecke, SK; Hsu, MA; Johnson, BG; Noone, S; Rasmussen, K; Thompson, LK | 1 |
| Arnt, J; Dahan, L; Haddjeri, N; Hertel, P; Husum, H; Mnie-Filali, O | 1 |
| Aliaga, M; Assié, MB; Barbara, M; Bardin, L; Carilla-Durand, E; Malfètes, N; Maraval, M; Newman-Tancredi, A | 1 |
| Auclair, AL; Barret-Grévoz, C; Barreto, M; Depoortère, R; Kleven, MS; Newman-Tancredi, A | 1 |
| De Carolis, L; Milella, MS; Nativio, P; Nencini, P; Passarelli, F; Scaccianoce, S; Schepisi, C | 1 |
| Gyertyán, I; Kiss, B; Román, V; Sághy, K; Szombathelyi, Z | 1 |
| Horikawa, H; Kanba, S; Kato, TA; Mizoguchi, Y; Monji, A; Sato-Kasai, M; Seki, Y; Yoshiga, D | 1 |
| De Santis, M; Deng, C; Huang, XF; Lian, J; Pan, B | 1 |
| Deng, C; Huang, XF; Lian, J; Pan, B | 1 |
| Deng, C; Huang, XF; Pan, B | 2 |
| Chen, AQ; Chen, H; Chen, L; Chen, WF; Chen, XY; Liu, HX; Liu, HY; Pang, YY; Sheng, Q; Wang, Y; Xue, Y; Yang, YT | 1 |
17 other study(ies) available for haloperidol and benzoxazoles
| Article | Year |
|---|---|
[Dissociation of two components of rat behaviour by psychotropic drugs. Utilization for studying anxiolytic drugs].
Topics: Amobarbital; Animals; Benzoxazoles; Chlormezanone; Chlorpromazine; Dextroamphetamine; Diazepam; Ethanol; Exploratory Behavior; Haloperidol; Locomotion; Male; Mephenesin; Meprobamate; Oxazepam; Prazepam; Rats; Tranquilizing Agents | 1973 |
[Preliminary pharmacological studies on the central action of phenyl- and piperidinemethyl derivatives of benzoxazolone-2].
Topics: Animals; Benzoxazoles; Body Temperature; Brain; Catalepsy; Drug Synergism; Female; Haloperidol; Hexobarbital; Humans; Mice; Mice, Inbred Strains; Motor Activity; Sleep | 1981 |
Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine.
Topics: Animals; Benzoxazoles; Conditioning, Operant; Desipramine; Dopamine; Female; Haloperidol; Injections, Intraventricular; Injections, Subcutaneous; Intracellular Signaling Peptides and Proteins; Limbic System; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Microdialysis; Microinjections; Morphine; Motor Activity; Naphthyridines; Neuropeptides; Nucleus Accumbens; Orexins; Oxidopamine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reward; RNA, Messenger; Tyrosine 3-Monooxygenase; Urea; Ventral Tegmental Area | 2006 |
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Binding, Competitive; Cell Line; Clozapine; Dioxanes; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Male; Piperazines; Prolactin; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Spodoptera; Sulfur Radioisotopes; Tropanes | 2006 |
The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Topics: Action Potentials; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Benzoxazoles; Brain; Dopamine; Drug Interactions; Haloperidol; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neurons; Neuropeptides; Olanzapine; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Time Factors; Urea | 2007 |
The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptoms.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Benzodiazepines; Benzoxazoles; Catalepsy; Haloperidol; Intracellular Signaling Peptides and Proteins; Locomotion; Male; Naphthyridines; Neuropeptides; Olanzapine; Orexins; Prolactin; Rats; Rats, Sprague-Dawley; Risperidone; Urea | 2007 |
Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Apomorphine; Aripiprazole; Benzoxazoles; Dopamine; Dopamine D2 Receptor Antagonists; Electroshock; Haloperidol; Male; Neurons; Piperazines; Pyridines; Quinolones; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Ultrasonics; Ventral Tegmental Area; Vocalization, Animal | 2009 |
The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benzofurans; Benzoxazoles; Benzylamines; Blood Glucose; Clozapine; Corticosterone; Cyclopentanes; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Thiazoles | 2008 |
Differences among conventional, atypical and novel putative D(2)/5-HT(1A) antipsychotics on catalepsy-associated behaviour in cynomolgus monkeys.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Aripiprazole; Benzamides; Benzodiazepines; Benzoxazoles; Catalepsy; Clozapine; Dibenzothiazepines; Dioxanes; Dopamine Antagonists; Female; Haloperidol; Macaca fascicularis; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Remoxipride; Risperidone; Serotonin Receptor Agonists; Thiazoles; Tropanes; Video Recording | 2009 |
Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia.
Topics: Animals; Benzoxazoles; Cerebral Cortex; Conditioning, Operant; Corticosterone; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drinking; Drug Synergism; Haloperidol; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neuropeptides; Orexins; Psychotic Disorders; Quinpirole; Rats; Rats, Sprague-Dawley; Urea | 2010 |
Cariprazine (RGH-188), a D₃-preferring dopamine D₃/D₂ receptor partial agonist antipsychotic candidate demonstrates anti-abuse potential in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cocaine-Related Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Piperazines; Quinolones; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Secondary Prevention; Substance-Related Disorders | 2013 |
Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-γ-stimulated microglia in co-culture model.
Topics: Animals; Animals, Newborn; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Brain; Cell Survival; Cells, Cultured; Coculture Techniques; Drug Interactions; Haloperidol; Interferon-gamma; Microglia; Minocycline; Myelin Proteolipid Protein; Nitrites; Oligodendroglia; Piperazines; Quinolinium Compounds; Quinolones; Rats; STAT1 Transcription Factor | 2013 |
Different effects of bifeprunox, aripiprazole, and haloperidol on body weight gain, food and water intake, and locomotor activity in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Drinking Behavior; Feeding Behavior; Haloperidol; Male; Motor Activity; Piperazines; Quinolones; Rats; Rats, Sprague-Dawley; Weight Gain | 2014 |
Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Haloperidol; Male; Nucleus Accumbens; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Signal Transduction | 2016 |
Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; beta Catenin; Blotting, Western; Brain; Dishevelled Proteins; Glycogen Synthase Kinase 3 beta; Haloperidol; Male; Phosphorylation; Piperazines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Signal Transduction | 2016 |
Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.
Topics: Action Potentials; Animals; Benzoxazoles; Globus Pallidus; Haloperidol; Male; Naphthyridines; Neurons; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Oxidopamine; Parkinson Disease; Postural Balance; Rats; Rats, Wistar; Urea | 2016 |
Chronic administration of aripiprazole activates GSK3β-dependent signalling pathways, and up-regulates GABAA receptor expression and CREB1 activity in rats.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Benzoxazoles; Cyclic AMP Response Element-Binding Protein; Glycogen Synthase Kinase 3 beta; Haloperidol; Piperazines; Prefrontal Cortex; Rats; Signal Transduction; Up-Regulation | 2016 |